JO
CBST

John Overdeck’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

John Overdeck’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-175,094
Closed -$12.2M – 2355
2014
Q2 		$12.2M Buy
175,094
+104,623
+148% +$7.12M 0.06% 433
2014
Q1 		$5.16M Buy
+70,471
New +$5.25M 0.03% 627
2013
Q4 		– Sell
-195,200
Closed -$12.4M – 2536
2013
Q3 		$12.4M Sell
195,200
-3,747
-2% -$226K 0.08% 304
2013
Q2 		$9.61M Buy
+198,947
New +$9.78M 0.07% 353

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

John Overdeck's CBST Position: Q3 2014 in Review

John Overdeck sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 175,094 shares — an estimated $12.2M sold.

John Overdeck first reported a position in CBST in Q2 2013 and held it in 4 quarters. The position peaked at $12.4M in Q3 2013. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • John Overdeck reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • John Overdeck sold 175,094 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $12.2M.
  • John Overdeck first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • John Overdeck's CUBIST PHARMACEUTICALS INC position peaked at $12.4M in Q3 2013.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on Two Sigma Investments's 13F filing for Q3 2014, filed 14 Nov 2014.